The Global Fund has established framework agreements with manufacturers of antiretroviral medicines with the aim to achieve lower prices and also ensure the sustainable and reliable on-time supply of the full range of the needed ARVs.
The prices included in this list are the prices at which the Global Fund Pooled Procurement Mechanism aims to deliver the health products at or below throughout the grant implementation period (2021-2023) as recommended in the Global Fund Guidelines for Grant Budgeting for health products.